Journal article
Machine learning and clinician predictions of antibiotic resistance in Enterobacterales bloodstream infections
- Abstract:
-
Background
Patients with Gram-negative bloodstream infections are at risk of serious adverse outcomes without active treatment, but identifying who has antimicrobial resistance (AMR) to target empirical treatment is challenging.
Methods
We used XGBoost machine learning models to predict antimicrobial resistance to seven antibiotics in patients with Enterobacterales bloodstream infection. Models were trained using hospital and community data from Oxfordshire, UK, for patients with positive blood cultures between 01-January-2017 and 31-December-2021. Model performance was evaluated by comparing predictions to final microbiology results in test datasets from 01-January-2022 to 31-December-2023 and to clinicians’ prescribing.
Findings
4709 infection episodes were used for model training and evaluation; antibiotic resistance rates ranged from 7–67%. In held-out test data, resistance prediction performance was similar for the seven antibiotics (AUCs 0.680 [95%CI 0.641–0.720] to 0.737 [0.674–0.797]). Performance improved for most antibiotics when species identifications (available ∼24 h later) were included as model inputs (AUCs 0.723 [0.652–0.791] to 0.827 [0.797–0.857]). In patients treated with a beta-lactam, clinician prescribing led to 70% receiving an active beta-lactam: 44% were over-treated (broader spectrum treatment than needed), 26% optimally-treated (narrowest spectrum active agent), and 30% under-treated (inactive beta-lactam). Model predictions without species data could have led to 79% of patients receiving an active beta-lactam: 45% over-treated, 34% optimally-treated, and 21% under-treated.
Conclusions
Predicting AMR in bloodstream infections is challenging for both clinicians and models. Despite modest performance, machine learning models could still increase the proportion of patients receiving active empirical treatment by up to 9% over current clinical practice in an environment prioritising antimicrobial stewardship.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.2MB, Terms of use)
-
(Preview, Supplementary materials, pdf, 4.0MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jinf.2024.106388
Authors
- Publisher:
- Elsevier
- Journal:
- Journal of Infection More from this journal
- Volume:
- 90
- Issue:
- 2
- Article number:
- 106388
- Publication date:
- 2024-12-29
- Acceptance date:
- 2024-12-20
- DOI:
- EISSN:
-
1532-2742
- ISSN:
-
0163-4453
- Language:
-
English
- Keywords:
- Pubs id:
-
2074016
- Local pid:
-
pubs:2074016
- Deposit date:
-
2025-01-05
- ARK identifier:
Terms of use
- Copyright holder:
- Yuan et al
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association. User License: Creative Commons Attribution (CC BY 4.0)
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record